To

All Trading Members of the Exchanges

Sub: Final Order regarding Ankur Agarwal in the matter of Arvind Remedies Limited.

SEBI vide its order no. WTM/SM/IVD/ID18/26064/2023-24 dated April 28, 2023, has inter-alia issued following directions:

• The Noticee is hereby restrained from accessing the securities market, and further prohibited from buying, selling or otherwise dealing in securities, directly or indirectly, and associating with the securities market in any manner for a period of six months from the date of this Order.

• It is clarified that obligation of the Noticee, in respect of settlement of securities, if any, purchased or sold in the cash segment of the recognized stock exchange(s), as existing on the date of this Order, can take place irrespective of the restraint/prohibition imposed by this Order, in respect of pending transactions, if any. Further, all open positions, if any, of the Noticee in the F&O segment of the stock exchange, are permitted to be squared off, irrespective of the restraint/prohibition imposed by this Order.

This Order is effective from the date of the order.

A copy of the said Order is attached herewith and available on the SEBI website www.sebi.gov.in.

Trading members are advised to take note of the same and ensure compliance.

Jeevan Noronha                                                                                          Shubham Benere

Regulatory Correspondence                                                                     Regulatory Correspondence                                                        

Date: April 28, 2023